The use of supersaturated oxygen therapy in patients with late-presentation anterior ST-segment elevation myocardial infarction

IF 3.2 2区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

International journal of cardiology Pub Date : 2025-04-08 DOI:10.1016/j.ijcard.2025.133256

Paige E. Carlson , Sarah Schwager , Katianna Feldewerd , Stephanie Schmidt , Michelle Campbell , Seth Bergstedt , Joao L. Cavalcante , Jay H. Traverse

{"title":"The use of supersaturated oxygen therapy in patients with late-presentation anterior ST-segment elevation myocardial infarction","authors":"Paige E. Carlson , Sarah Schwager , Katianna Feldewerd , Stephanie Schmidt , Michelle Campbell , Seth Bergstedt , Joao L. Cavalcante , Jay H. Traverse","doi":"10.1016/j.ijcard.2025.133256","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Patients with late-presentation anterior ST-elevation myocardial infarction (STEMI) are at increased risk of heart failure and mortality due to greater infarct size and microvascular injury including microvascular obstruction (MVO) and intramyocardial hemorrhage (IMH). Apart from primary percutaneous coronary intervention (PCI), no additional therapies are available for this high-risk group. Supersaturated oxygen therapy (SSO<sub>2</sub>) is utilized for anterior STEMIs with ischemic times under 6 h and may reduce infarct size. We investigated if SSO<sub>2</sub> therapy may provide a clinical benefit for late-presentation anterior STEMI patients.</div></div><div><h3>Methods</h3><div>SSO<sub>2</sub> therapy was administered to 19 late-presentation anterior STEMI patients (12 males (M), 7 females (F); 60 yr.) for 60-min following primary PCI. Patients underwent cardiac MRI (CMR) prior to discharge for evaluation of infarct size, MVO, and IMH. Results were compared to a control group of 31 late-presentation anterior STEMI patients (19 M, 12F; 59 yr.) who received PCI and CMR but not SSO<sub>2</sub>.</div></div><div><h3>Results</h3><div>The left anterior descending artery (LAD) was completely occluded in 89 % of SSO<sub>2</sub> patients and 77 % of control patients prior to PCI. Final TIMI 3 flow was achieved in 84 % of all patients. Ejection fraction at baseline as well as infarct size, were similar between the two groups. Significantly fewer SSO<sub>2</sub> patients had MVO (75 % vs 100 %, <em>p</em> = 0.01) and residual ST-segment elevation following PCI was significantly less in the SSO2 group suggestive of improved microvascular perfusion. Mortality was significantly reduced in the SSO2 group following STEMI compared to control patients (0 % vs 23 %, <em>p</em> = 0.03).</div></div><div><h3>Conclusions</h3><div>SSO<sub>2</sub> can be safely delivered to late-presentation anterior STEMI patients and results in less MVO and less adverse events including all-cause mortality. SSO<sub>2</sub> therapy may represent a new treatment for this high-risk patient group.</div></div>","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"431 ","pages":"Article 133256"},"PeriodicalIF":3.2000,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of cardiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0167527325002992","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Patients with late-presentation anterior ST-elevation myocardial infarction (STEMI) are at increased risk of heart failure and mortality due to greater infarct size and microvascular injury including microvascular obstruction (MVO) and intramyocardial hemorrhage (IMH). Apart from primary percutaneous coronary intervention (PCI), no additional therapies are available for this high-risk group. Supersaturated oxygen therapy (SSO₂) is utilized for anterior STEMIs with ischemic times under 6 h and may reduce infarct size. We investigated if SSO₂ therapy may provide a clinical benefit for late-presentation anterior STEMI patients.

Methods

SSO₂ therapy was administered to 19 late-presentation anterior STEMI patients (12 males (M), 7 females (F); 60 yr.) for 60-min following primary PCI. Patients underwent cardiac MRI (CMR) prior to discharge for evaluation of infarct size, MVO, and IMH. Results were compared to a control group of 31 late-presentation anterior STEMI patients (19 M, 12F; 59 yr.) who received PCI and CMR but not SSO₂.

Results

The left anterior descending artery (LAD) was completely occluded in 89 % of SSO₂ patients and 77 % of control patients prior to PCI. Final TIMI 3 flow was achieved in 84 % of all patients. Ejection fraction at baseline as well as infarct size, were similar between the two groups. Significantly fewer SSO₂ patients had MVO (75 % vs 100 %, p = 0.01) and residual ST-segment elevation following PCI was significantly less in the SSO2 group suggestive of improved microvascular perfusion. Mortality was significantly reduced in the SSO2 group following STEMI compared to control patients (0 % vs 23 %, p = 0.03).

Conclusions

SSO₂ can be safely delivered to late-presentation anterior STEMI patients and results in less MVO and less adverse events including all-cause mortality. SSO₂ therapy may represent a new treatment for this high-risk patient group.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

International journal of cardiology 医学-心血管系统

CiteScore

6.80

自引率

5.70%

发文量

758

审稿时长

44 days

期刊介绍： The International Journal of Cardiology is devoted to cardiology in the broadest sense. Both basic research and clinical papers can be submitted. The journal serves the interest of both practicing clinicians and researchers. In addition to original papers, we are launching a range of new manuscript types, including Consensus and Position Papers, Systematic Reviews, Meta-analyses, and Short communications. Case reports are no longer acceptable. Controversial techniques, issues on health policy and social medicine are discussed and serve as useful tools for encouraging debate.